Skip to main content
. 2020 May 16;13:100203. doi: 10.1016/j.lrr.2020.100203

Table 1.

CN-AML patient's characteristics.

Item No (%)
Sex
 Male 45
 Female 35
FAB subtypes
 M0 3 (3.7%)
 M1 15(18.7%)
 M2 17(21.3%)
 M4 35(43.8%)
 M5 10(12.5%)
Induction of remission
 Responder 45
 Non-responder 35
CN AML
Positive CD25+/CD123+ co-expression
17
CN-AML
Lack CD25+/CD123+ Co-expression
63
Deaths
 Alive 47
 Dead 33